Found: 3
Select item for more details and to access through your institution.
Subjective expectations regarding longevity and future health: a cross‐sectional survey among patients with Crohn's disease.
- Published in:
- Colorectal Disease, 2021, v. 23, n. 1, p. 105, doi. 10.1111/codi.15357
- By:
- Publication type:
- Article
Randomised clinical trial: mesalazine versus placebo in the prevention of diverticulitis recurrence.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2017, v. 46, n. 3, p. 282, doi. 10.1111/apt.14152
- By:
- Publication type:
- Article
Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 8, p. 911, doi. 10.1111/j.1365-2036.2011.04827.x
- By:
- Publication type:
- Article